Literature DB >> 11711547

Possible existence of common internalization mechanisms among arginine-rich peptides.

Tomoki Suzuki1, Shiroh Futaki, Miki Niwa, Seigo Tanaka, Kunihiro Ueda, Yukio Sugiura.   

Abstract

Basic peptides such as human immunodeficiency virus type 1 (HIV-1) Tat-(48-60) and Drosophila Antennapedia-(43-58) have been reported to have a membrane permeability and a carrier function for intracellular protein delivery. We have shown that not only Tat-(48-60) but many arginine-rich peptides, including HIV-1 Rev-(34-50) and octaarginine (Arg(8)), efficiently translocated through the cell membranes and worked as protein carriers (Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., and Sugiura, Y. (2001) J. Biol. Chem. 276, 5836-5840). Quantification and time course analyses of the cellular uptake of the above peptides by mouse macrophage RAW264.7, human cervical carcinoma HeLa, and simian kidney COS-7 cells revealed that Rev-(34-50) and Arg(8) had a comparable translocation efficiency to Tat-(48-60). Internalization of Tat-(48-60) and Rev-(34-50) was saturable and inhibited by the excess addition of the other peptide. Typical endocytosis and metabolic inhibitors had little effect on the internalization. The uptake of these peptides was significantly inhibited in the presence of heparan sulfate or chondroitin sulfates A, B, and C. Treatment of the cells with the anti-heparan sulfate antibody or heparinase III also lowered the translocation of these peptides. These results strongly suggest that the arginine-rich basic peptides share a certain part of the internalization pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711547     DOI: 10.1074/jbc.M110017200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  105 in total

Review 1.  Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.

Authors:  Guillaume Drin; Christophe Rousselle; Jean-Michel Scherrmann; Anthony R Rees; Jamal Temsamani
Journal:  AAPS PharmSci       Date:  2002

2.  Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.

Authors:  Rachel Tréhin; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle; Hanne M Nielsen
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

3.  Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58).

Authors:  Rachel Tréhin; Ulrike Krauss; Roman Muff; Martina Meinecke; Annette G Beck-Sickinger; Hans P Merkle
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 4.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

5.  Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells.

Authors:  Y Elaine Lau; Annett Rozek; Monisha G Scott; Danika L Goosney; Donald J Davidson; Robert E W Hancock
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 6.  Protein transduction technology.

Authors:  Masayuki Matsushita; Hideki Matsui
Journal:  J Mol Med (Berl)       Date:  2005-02-10       Impact factor: 4.599

Review 7.  Inhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteins.

Authors:  Lucian Soane; Gary Fiskum
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

Review 8.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

9.  A critical reassessment of penetratin translocation across lipid membranes.

Authors:  Elsa Bárány-Wallje; Sandro Keller; Steffen Serowy; Sebastian Geibel; Peter Pohl; Michael Bienert; Margitta Dathe
Journal:  Biophys J       Date:  2005-07-22       Impact factor: 4.033

Review 10.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.